Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Venous Thrombosis 2Pulmonary Embolism 2Hemorrhage 2Venous Thromboembolism 1Thromboembolism 1Thrombocytopenia 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Tranexamic Acid 2Misoprostol 2Enoxaparin 2Dalteparin 2carbetocin 1Vitamin B 6 1Vasopressins 1Uterine Artery Embolization 1Tourniquets 1Tinzaparin 1Terlipressin 1Sodium Chloride 1Sensitivity Training Groups 1Rivaroxaban 1Oxytocin 1Ibuprofen 1Ethamsylate 1Bupivacaine 1Arginine Vasopressin 1Arginine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Hemorrhage × Dalteparin × Clear all
NCT04731558 2025-02-14

PREPOSTEROUS

Helsinki University Central Hospital

Phase 4 Recruiting
1,012 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed
116 enrolled
Thoracic

Hemorrhage, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡